As of 25 Oct 2024, ImmunoPrecise Antibodies total assets is $57.15M, an decrease of -16.91% to 2022. This figure includes all the resources and properties owned by ImmunoPrecise Antibodies, reflecting its financial standing at that time.
Year | Total Assets | Change |
---|---|---|
2023 | $57.15M | -16.91% |
2022 | $68.78M | 39.86% |
2021 | $49.18M | 145.60% |
2020 | $20.02M | -3.82% |
2019 | $20.82M | - |